CA9 and renal cell carcinoma: The fusion protein was able to recognize CAIX both in vitro and in vivo, when tested on a human renal cell carcinoma cell line (SKRC52, which naturally express the antigen) and in a murine colon carcinoma cell line (CT26-CAIX, which had been transfected with the human antigen).